Virtu Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding LXRX
AG
SL
Virtu Financial's LXRX Position: Q3 2026 in Review
Virtu Financial opened a new position in Lexicon Pharmaceuticals (LXRX) in Q3 2026: 32,497 shares worth $61K. The stake represents ﹤0.01% of the portfolio and ranks #1234 among its holdings. This is a return to the name: Virtu Financial previously reported a position in LXRX as recently as Q4 2025.
Virtu Financial first reported a position in LXRX in Q1 2014 and has held it in 12 quarters since. The position peaked at $196K in Q1 2019. 157 funds tracked by Wall St. Rank hold LXRX as of Q3 2026.
- Virtu Financial held 32,497 shares of Lexicon Pharmaceuticals worth $61K as of Q3 2026.
- Lexicon Pharmaceuticals was a new Virtu Financial position in Q3 2026.
- Lexicon Pharmaceuticals made up ﹤0.01% of Virtu Financial's portfolio in Q3 2026, its #1234 holding.
- Virtu Financial first reported a position in Lexicon Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
- Virtu Financial's Lexicon Pharmaceuticals position peaked at $196K in Q1 2019.
- 157 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.